Losartan and anaemia of end-stage renal disease [8]

Lancet

Volumn 352, Issue 9141, 1998, Pages 1708-

  Lang, S M ^a   Schiffl, H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMODIALYSIS FLUID; HEMOGLOBIN; LOSARTAN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; LETTER; PRIORITY JOURNAL;

EID: 0032556352     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)61486-9     Document Type: Letter

References (3)

1. A Schwarzbeck KW Wittenmeier U Hällfrizsch Anaemia in dialysis patients as a side-effect of sartanes Lancet 352 1998 286
2. BI Shand NL Gilchrist MG Nicholls Effect of losartan on haemotology and haemorheology in elderly patients with essential hypertension J Hum Hypertens 9 1995 233 235
3. R Toto P Shultz L Jaij Efficacy and tolerability of losartan in hypertensive patients with renal impairment Hypertension 31 1998 684 691